AKT1 and vitiligo: Based on the results of network pharmacology, molecular docking was performed to validate the binding modes of the top three active components (i.e., luteolin, quercetin, wogonin) and the top three FHB-vitiligo targets (i.e., RELA, STAT3, AKT1).